American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing

Hereditary and acquired thrombophilia are risk factors for venous thromboembolism (VTE). Whether testing helps guide management decisions is controversial. These evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about thrombophilia testing. ASH...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood advances Ročník 7; číslo 22; s. 7101 - 7138
Hlavní autoři: Middeldorp, Saskia, Nieuwlaat, Robby, Baumann Kreuziger, Lisa, Coppens, Michiel, Houghton, Damon, James, Andra H., Lang, Eddy, Moll, Stephan, Myers, Tarra, Bhatt, Meha, Chai-Adisaksopha, Chatree, Colunga-Lozano, Luis E., Karam, Samer G., Zhang, Yuan, Wiercioch, Wojtek, Schünemann, Holger J., Iorio, Alfonso
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Elsevier Inc 28.11.2023
The American Society of Hematology
Témata:
Anticoagulants - therapeutic use
Antithrombins - therapeutic use
Clinical Guidelines
Female
Hematology
Humans
Pregnancy
Thrombophilia - diagnosis
Thrombophilia - etiology
United States
Venous Thromboembolism - diagnosis
Venous Thromboembolism - drug therapy
Venous Thromboembolism - etiology
United States
ISSN:2473-9529, 2473-9537, 2473-9537
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Hereditary and acquired thrombophilia are risk factors for venous thromboembolism (VTE). Whether testing helps guide management decisions is controversial. These evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about thrombophilia testing. ASH formed a multidisciplinary guideline panel covering clinical and methodological expertise and minimizing bias from conflicts of interest. The McMaster University GRADE Centre provided logistical support, performed systematic reviews, and created evidence profiles and evidence-to-decision tables. The Grading of Recommendations Assessment, Development, and Evaluation approach (GRADE) was used. Recommendations were subject to public comment. The panel agreed on 23 recommendations regarding thrombophilia testing and associated management. Nearly all recommendations are based on very low certainty in the evidence due to modeling assumptions. The panel issued a strong recommendation against testing the general population before starting combined oral contraceptives (COCs) and conditional recommendations for thrombophilia testing in the following scenarios: (a) patients with VTE associated with nonsurgical major transient or hormonal risk factors; (b) patients with cerebral or splanchnic venous thrombosis, in settings where anticoagulation would otherwise be discontinued; (c) individuals with a family history of antithrombin, protein C, or protein S deficiency when considering thromboprophylaxis for minor provoking risk factors and for guidance to avoid COCs/hormone replacement therapy; (d) pregnant women with a family history of high-risk thrombophilia types; and (e) patients with cancer at low or intermediate risk of thrombosis and with a family history of VTE. For all other questions, the panel provided conditional recommendations against testing for thrombophilia.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2473-9529
2473-9537
2473-9537
DOI:10.1182/bloodadvances.2023010177